Koers Sunshine Heart Inc Nasdaq
Aandelen
US86782U1060
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 8,98 mln. 8,35 mln. | Omzet 2025 * | 10,32 mln. 9,6 mln. | Marktkapitalisatie | 2,59 mln. 2,41 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -10 mln. -9,3 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,37 mln. | EV/omzet 2024 * | 0,29 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,25 x |
K/w-verhouding 2024 * |
-0,15
x | K/w-verhouding 2025 * |
-0,53
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,21% |
Recentste transcriptie over Sunshine Heart Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 07-05-19 |
Robert Scott
DFI | Director of Finance/CFO | 44 | 01-01-13 |
John Erb
CHM | Chairman | 75 | 01-09-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Erb
CHM | Chairman | 75 | 01-09-12 |
Director/Board Member | 61 | 01/11 | |
Gregory Waller
BRD | Director/Board Member | 74 | 03-08-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,18% | 211 mld. | |
+8,00% | 185 mld. | |
+31,86% | 158 mld. | |
+33,21% | 113 mld. | |
+2,70% | 64,32 mld. | |
+21,14% | 55,66 mld. | |
+0,11% | 48,41 mld. | |
-6,76% | 37,82 mld. | |
+0,78% | 35,57 mld. |